Legionella Pneumophila
======================

*Legionella pneumophila* is a facultative intracellular lung pathogen (Horwitz and Silverstein, [@B47]) and the causative agent of Legionnaires' disease (LD), a serious and often fatal, life-threatening bacterial pneumonia. LD is also a relatively common cause of community-acquired and nosocomial pneumonia in adults. *L. pneumophila* was recognized in 1976 after an outbreak of pneumonia at an American Legion convention in Philadelphia. Soon after, the etiologic agent was identified as a fastidious Gram-negative bacillus and named *L. pneumophila*. Although several other species of the genus *Legionella* were subsequently identified, the great majority of LD is caused by *L. pneumophila* (Marston et al., [@B65]; Yu et al., [@B101]). Most nosocomial infections and hospital outbreaks have been linked to contaminated air or water supplies. *L. pneumophila* has been recovered from different aquatic habitats including showers, streams, whirlpools, air conditioners, cooling towers, fountains, and spa baths (Fraser et al., [@B30]; Fliermans et al., [@B29]; Sethi and Brandis, [@B88]; Spitalny et al., [@B89]; Lettinga et al., [@B55]). Within water systems, *L. pneumophila* colonizes into biofilm; which are complex bacterial communities attached to a substratum by means of exopolysaccharides (EPS; Rogers et al., [@B81]). Biofilm develop into mushroom-like structures with water channels that allow access to nutrients and oxygen within these bacterial communities. *L. pneumophila* is able to obtain nutrients such as amino acids and organic carbon sources from the microbial consortium located in the biofilm (Watnick and Kolter, [@B98]). Humans are accidental dead-end hosts for *L. pneumophila*, thus, there is no person-to-person transmission whereas, protozoa are considered the environmental hosts for this intracellular pathogen, and are required for replication of biofilm-associated *L. pneumophila* (Rowbotham, [@B83], [@B84]; Nash et al., [@B70]; Kuiper et al., [@B54]). While providing a niche for *L. pneumophila* replication, amoebae also protect *L. pneumophila* from harsh environmental conditions. Replication within different protozoa enhances bacterial multiplication in human alveolar macrophages. Growth within the protozoa also induces resistance to chemical disinfectant, biocides and antibiotics and induces phenotypic changes in *L. pneumophila* (Barker et al., [@B10], [@B11]; Abu Kwaik et al., [@B2]; Cirillo et al., [@B21]).

Risk Factors
============

The majority of people exposed to *L. pneumophila* remains asymptomatic or suffer only mild self-limiting infection. Susceptible patients to LD disease are likely to exhibit a defect in cell-mediated immunity rendering them less capable of limiting the early multiplication of *L. pneumophila*. Cigaret smoking, chronic lung disease, and immunosuppression (especially that caused by corticosteroid therapy) have been consistently implicated as risk factors (Carratala et al., [@B18]). Surgery is a major predisposing factor in nosocomial infection, with transplant recipients at highest risk. Other factors associated with the development of LD include, old age, cancer, and alcohol intake (Marston et al., [@B64]; Den Boer et al., [@B26]).

*L. Pneumophila* Multiplies in Human Monocytes, Alveolar Macrophages, and Human-Derived Cell Lines
==================================================================================================

*Legionella pneumophila* multiplies in human monocytes (Horwitz and Silverstein, [@B47]; Horwitz, [@B44]). The intracellular fate of *L. pneumophila* in both human and protozoa is similar, where the bacteria evade fusion of the phagosome to lysosome, although the mechanism maybe different in some aspects (Horwitz, [@B43],[@B44]; Horwitz and Maxfield, [@B46]; Bozue and Johnson, [@B16]). Attachments and binding of *L. pneumophila* to the complement receptor 1 (CR1), and complement receptor 3 (CR3) on human phagocytic cells is followed by entry into these cells. In some cases, the entry of the pathogen is mediated by "coiling phagocytosis," in which a single long phagocyte pseudopod coils around the bacterium as it is internalized (Horwitz, [@B45]; Payne and Horwitz, [@B76]; Figure [1](#F1){ref-type="fig"}). Following phagocytosis, *L. pneumophila* avoids interaction with endosomes, early and late lysosomes, and instead, fuses transiently with mitochondria and intercepts the endoplasmic reticulum (ER) exit vesicles (Horwitz, [@B44]; Swanson and Isberg, [@B90]; Kagan and Roy, [@B53]; Liang et al., [@B58]; Isberg et al., [@B50]). The bacteria maintain interactions with ER-derived vesicles and replicate in a vacuole surrounded by a membrane that resembles rough ER (Horwitz and Silverstein, [@B47]; Horwitz, [@B44]; Figure [1](#F1){ref-type="fig"}). The *L. pneumophila*-containing vacuole (LCV) remains studded with ribosomes until hundreds of the bacteria fill the vacuole and the monocyte ruptures (Figure [1](#F1){ref-type="fig"}; Nash et al., [@B70]). In contrast, formalin-killed *L. pneumophila* does not inhibit fusion or induce the formation of specialized phagosome and the dead bacteria are degraded within the phagolysosome (Horwitz and Silverstein, [@B47]; Horwitz, [@B44]).

![**Diagram depicting survival mechanisms employed by *L. pneumophila* in human phagocytes**. Upon entry into a human phagocyte, *L. pneumophila* becomes contained into a vacuole called *Legionella*-containing phagosome that avoids the typical fusion with the lysosome, and instead remodels into an ER-like vesicle allowing bacterial replication (1). *L. pneumophila* promotes the cleavage of Rabaptin-5 by caspase-3, thus preventing the default phagosome--lysosome fusion (2). *L. pneumophila* does not activate caspase-1 and -7 in human monocytes, consequently aborting the phagosome--lysosome fusion (3). This pathogen inhibits host cell apoptosis by up regulating anti-apoptotic genes (4). *L. pneumophila* controls the local balance of activating cytokines (INF-γ, TNF-α) that inhibit its replication, and inhibiting cytokines (IL-10) that allow its survival (5). *L. pneumophila* activates the NF-κB pathway to maintain host cell survival (6). *L. pneumophila* modulates other innate immune responses to establish a replicative niche (7).](fmicb-01-00133-g001){#F1}

Alveolar macrophages are the most abundant potential effector cells in the lung and play a role in host defense against *L. pneumophila* (Nash et al., [@B70]). *L. pneumophila* that reaches the alveoli encounters and multiplies in human alveolar macrophages at the site of infection, which is crucial to the pathogenesis of LD (Green, [@B36]; Goldstein et al., [@B35]). Lung tissue specimens from LD patients frequently contain large numbers of intracellular *L. pneumophila* (Winn Jr. and Myerowitz, [@B99]; Nash et al., [@B70]). Furthermore, alveolar macrophages are a major feature of the alveolar secretions in lung biopsies from patients with LD (Winn Jr. and Myerowitz, [@B99]; Nash et al., [@B70]).

Beside human monocytes and alveolar macrophages, investigators have employed a variety of cell lines that not only have similar characteristics to human phagocytes, but are also capable of supporting growth of this intracellular pathogen. For example, *L. pneumophila* multiplies within and kills HL-60 cells, a macrophage-like cell line that is derived from promyelocyte (Marra et al., [@B63]). In HL-60 cells, *L. pneumophila* enters by adhering to the CR3 and is taken by coiling phagocytosis. Similar to human phagocytes, the LCV is surrounded by ER-derived vesicles studded with ribosomes and therefore, HL-60 cells are utilized as a model to study the interaction of human macrophages with the LD bacterium (Marra et al., [@B63]). Similarly, *L. pneumophila* grows within U937 cells; a human monocytes lymphoma cell line that displays many monocytic features and can be maintained continuously in culture (Pearlman et al., [@B77]). These cells can be differentiated to adherent, non-replicative cells with characteristics of tissue macrophages. Additionally, they express surface markers specific for cells of monocyte lineage and are able to differentiate between virulent and avirulent strains of *L. pneumophila*. Their activation state is controlled experimentally and consequently can be standardized (Rovera et al., [@B82]). THP-1 is another human monocytic cell line that matures into macrophage-like adherent cells following stimulation with phorbol esters or 1,25-dihydroxyvitamin D3. Cirillo et al. ([@B21]) reported that *L. pneumophila* could invade and multiply within THP-1 cells in a manner similar to that in human monocytes and macrophages. Mono Mac 6 (MM6) is an additional example of human monocytic cell line. MM6 was generated from peripheral blood of patient with monoblastic leukemia. Phenotypically and functionally, MM6 represents a more mature macrophage-like cell line. Unlike the other monoblastic cell lines U937 and THP-1, MM6 does not require stimulation by phorbol esters or 1,25-dihydroxyvitamin D3 and expresses several markers that are lacking in U937 and THP-1 (Ziegler-Heitbrock et al., [@B102]; Neumeister et al., [@B74]). MM6 has been successfully utilized to study the molecular pathogenesis of *L. pneumophila* and other intracellular pathogens that can replicate within human monocytes (Neumeister, [@B72]). Furthermore, non-professional phagocytic cell lines have been utilized to study *L. pneumophila* replication such as A549, a human epithelial cell line derived from a human lung cancer. They are non-professional phagocytes and have characteristics of type II alveolar epithelial cells (Maruta et al., [@B67]). It has been shown that *L. pneumophila* is internalized and replicate effectively in A549 cells (Maruta et al., [@B67]; Vinzing et al., [@B95]; Bartfeld et al., [@B12]). Therefore, many human-derived cell lines have been used to characterize the molecular mechanisms associated with *L. pneumophila* pathogenesis. While some features are unique to the interactions between *L. pneumophila* and specific host cells, the primary mechanisms of infection appears to be the same.

The Innate Immune Response of Primary Human Cells and Human-Derived Cell Lines to *L. Pneumophila*
==================================================================================================

Host cells express a range of receptors that act as microbial sensors. These receptors sense microorganisms and transduce signals that activate immune responses. Pathogen-associated molecular patterns (PAMPs) such as peptidoglycan, bacterial flagellin, and nucleic acid can be recognized by means of cell surface pattern recognition receptors (PRRs) named Toll-like receptors (TLRs) (Underhill et al., [@B94]; Janeway Jr. and Medzhitov, [@B52]; Takeda et al., [@B92]). TLRs recognize PAMPs via an extracellular domain and initiate inflammatory signaling pathways through an intracellular domain (Underhill et al., [@B94]; Janeway Jr. and Medzhitov, [@B52]; Takeda et al., [@B92]). Humans express functional TLRs 1--10 whereas mice express TLRs 1--7 and 9--13 (Table [1](#T1){ref-type="table"}; Vinzing et al., [@B95]).

###### 

**Differences between human and mice cells that affects *Legionella* permissiveness**.

              Human                                                 Mice                                                  References
  ----------- ----------------------------------------------------- ----------------------------------------------------- --------------------------------
  NLRs        23 members                                            34 members                                            Abdelaziz et al. ([@B1] \#149)
  NAIPs       1                                                     7 paralogs                                            Vinzing et al. ([@B95] \#7)
  Caspases    11 caspases                                           10 caspases                                           
  Caspase-1   Not activated in response to *Legionella* infection   Activated in response to *Legionella* infection       Akhter et al. ([@B4] \#5)
  Caspase-7   Not activated in response to *Legionella* infection   Activated in response to *Legionella* infection       Akhter et al. ([@B4] \#5)
  Caspase-3   activated in response to *Legionella* infection       Not activated in response to *Legionella* infection   Santic et al. ([@B85] \#8)

Other means of sensing the presence of microbes or their factors in the host cytosol is mediated by NOD-like receptors (NLRs), which in turn, initiate signaling cascades that mediate the production of inflammatory cytokines, recruitment of phagocytic cells and direction of the innate and the acquired immune responses. There are 23 NLRs in human and 34 in mice (Abdelaziz et al., [@B1]; Amer, [@B8]). Typically, NLRs are composed of a leucine-rich repeat (LRR) domain, a central nucleotide oligomerization domain (NOD) and N-terminal effector binding domain, which consists of caspase recruitment domain (CARD) and the pyrin domain.

One of the major NLRs contributing to the restriction of *L. pneumophila* infection in human and in mice is NLRC4 (IPAF) (Damiano et al., [@B25]; Poyet et al., [@B78]; Amer et al., [@B7]; Vinzing et al., [@B95]; Akhter et al., [@B4]). Human NLRC4 is highly homologous to the mouse Nlrc4 and is expressed in human macrophages but not in human lung epithelial cells (Vinzing et al., [@B95]). Like most NLRs, mouse Nlrc4 assembles in a large multiprotein complex called the inflammasome leading to the activation of caspase-1. Caspases are family of cysteine proteases that play a distinct role in apoptosis and inflammation (Fink and Cookson, [@B28]). Caspases can be divided into two groups; one category of caspases is involved in apoptosis such as caspase-3 and -7 (Martinon and Tschopp, [@B66]). Another category is involved in inflammation and is required for cytokine processing (Creagh et al., [@B24]). As an inflammatory caspase, caspase-1 is required for the activation of cytokines such as IL-1β, IL-18, and IL-33 and induces a form of cell death named pyroptosis (Fink and Cookson, [@B28]). Wild-type mouse macrophages restrict *L. pneumophila* replication via caspase-1-mediated caspase-7 activation resulting in fusion of the LCV with the lysosome leading to bacterial degradation and growth restriction (Akhter et al., [@B4]). However, human monocytes do not activate caspase-1 and -7 upon *L. pneumophila* infection, allowing bacterial growth (Table [1](#T1){ref-type="table"}; Santic et al., [@B85]; Akhter et al., [@B4]). Although THP-1 cells were not shown to activate caspase-1 in response to *L. pneumophila*, the depletion of human NLRC4 allows more *L. pneumophila* replication (Vinzing et al., [@B95]). This data implies the existence of uncharacterized caspase-1-independent restriction mechanism of *L. pneumophila* replication in human phagocytes.

A subset of NLRs contains baculovirus inhibitor of apoptosis repeat domains (BIR) instead of CARD or pyrin domains. These proteins are called the neuronal apoptosis-inhibitory proteins (NAIPs). The LRR domain recognizes microbial products, while the BIR domains are essential for their interactions with caspase-3 and -7 (Liston et al., [@B60]; Takahashi et al., [@B91]; Diez et al., [@B27]). The importance of Naip5 during *L. pneumophila* infection stemmed from studies showing that the A/J mice are permissive to *L. pneumophila* in contrast to most other inbred mouse strains (Diez et al., [@B27]; Wright et al., [@B100]). Gros and his group identified 14 amino acid substitutions in the A/J derived Naip5 when compared to wild-type Naip5 and they proposed that several of these mutations are responsible for permissiveness to *L. pneumophila* (Beckers et al., [@B13]; Diez et al., [@B27]). Furthermore, in contrast to the seven mouse Naips, only one NAIP has been identified in human and exhibits 68% homology to the mouse C57BL/6 and A/J Naip5. Human NAIP is expressed in THP-1, primary macrophages, and A549 epithelial cells. Furthermore, depletion of the human orthologs of Naip5 results in increased replication of *L. pneumophila* in human THP-1 macrophages and A549 lung epithelial cells (Vinzing et al., [@B95]). However, the mechanism by which human NAIP restricts *L. pneumophila* replication is yet to be elucidated.

The Activation of Survival Pathways in *L. Pneumophila*-Infected Human Cells
============================================================================

Studies with the human macrophage-like U937 and human epithelial cells A549 showed that *L. pneumophila* induces the activation of the transcriptional regulator nuclear factor κB (NF-κB) upon infection (Losick and Isberg, [@B62]; Abu-Zant et al., [@B3]; Schmeck et al., [@B87]; Bartfeld et al., [@B12]). *L. pneumophila* induces biphasic activation of the NF-κB pathway. The early phase is strong, but transient and is flagellin, TLR5 and MYD88-dependent. It is terminated quickly to prevent the autotoxic overproduction of inflammatory mediators. *L. pneumophila* activates the NF-κB pathway in human epithelial cells leading to secretion of several cytokines and chemokines (Schmeck et al., [@B87]). This activation is beneficial for the host since it triggers the innate immune response. The second phase of NF-κB activation is characterized by long-term activation for up to 30 h. However, this phase is flagellin, TLR5, MYD88-independent (Bartfeld et al., [@B12]). The long-term activation of NF-κB is linked to bacterial replication and upregulation of anti-apoptotic genes (Bartfeld et al., [@B12]). Therefore, this phase seems to be beneficial for the pathogen. The mechanism for this late stage NF-κB activation is still unclear.

The Role of Caspase-3 in *L. Pneumophila* Infection of Human Cells
==================================================================

The host can employ several mechanisms to overcome intracellular infection. Among these, is the elimination of infected cells by caspase-mediated apoptosis. Arising reports demonstrate new distinct roles for executioner caspases independent of cell death (Li and Yuan, [@B57]; Walsh et al., [@B97]; Amer, [@B8]). *L. pneumophila* induces caspase-3 activation in human macrophages and U937 (Gao and Abu Kwaik, [@B32],[@B33]; Zink et al., [@B103]; Molmeret et al., [@B69]; Santic et al., [@B85]). The earlier studies with macrophages and epithelial cells demonstrated that high numbers of *L. pneumophila* induces apoptosis through activation of caspase-3 (Gao and Abu Kwaik, [@B32]; Neumeister et al., [@B73]). Remarkably, other studies demonstrated that the early caspase-3 activation by *L. pneumophila* is independent of the intrinsic and extrinsic pathways of apoptosis (Molmeret et al., [@B69]). Notably, at physiological levels of infection, *L. pneumophila* utilizes the early mild caspase-3 activation in human cells to evade the phagosome--lysosome fusion. Activation of caspase-3 by low numbers of *L. pneumophila* is accompanied with cleavage of rabaptin-5, a downstream effector of rab-5 (Molmeret et al., [@B69]). Rab-5 GTPase is involved in the maturation of the early endosome. Therefore, according to the number of *L. pneumophila* invading a human cell, caspase-3 activation can lead either to apoptosis or to delayed phagosome maturation.

Modulation of the Ubiquitination Machinery by *L. Pneumophila*
==============================================================

Several studies showed that in human cells, the LCV is decorated with polyubiquitinated proteins upon *L. pneumophila* infection (Ivanov and Roy, [@B51]). Ubiquitination is a reversible post-translational modification that controls the abundance of many critical regulatory proteins (Craig and Tyers, [@B23]; Lomma et al., [@B61]). Degradation of intracellular proteins is mediated via means of the ubiquitin system and its specificity is determined at the level of substrate recognition by the E3 ubiquitin ligases, that catalyzes binding of the activated ubiquitin to the target protein for degradation (Craig and Tyers, [@B23]). Additionally, the *L. pneumophila* genome encodes for proteins with F-box and U-box domains (Cazalet et al., [@B19]; Price et al., [@B79]; Lomma et al., [@B61]) that are similar to eukaryotic SCF ubiquitin ligases. F-box proteins are known components of E3 ubiquitin ligases named SCF complexes. The F-box motif within the F-box protein interacts with the components of the ubiquitin machinery while the protein--protein interaction domain selectively binds to specific substrate. The U-box is a domain of approximately 70 amino acids that is present in proteins from yeast to humans. Mammalian U-box proteins in conjugation with E1 and E2 mediate protein ubiquitination, and thus have been classified as E3 ligases (Hatakeyama et al., [@B37]). Three F-box-containing proteins have been shown to be required for intracellular replication of *L. pneumophila* in THP-1 macrophages and A549 cells, and single, double, or triple mutations in the F-box proteins impair infection within these cells (Lomma et al., [@B61]). Al-Khodor et al. ([@B6]) showed that the F-box-containing protein AnkB is required for intracellular replication of *L. pneumophila* within human monocytes-derived macrophages (hMDM). Furthermore, AnkB translocated to the host cytosol via the type IV secretion system mediates *L. pneumophila* replication via decorating the LCV with polyubiquitinated proteins (Price et al., [@B79]). The focal adhesion protein ParvB, is the target for AnkB (Lomma et al., [@B61]), and AnkB interferes with the ubiquitination of the ParvB, likely by competing with the eukaryotic E3 ligase for the protein--protein interaction domain of ParvB (Lomma et al., [@B61]). Therefore, *L. pneumophila* hijacks the host cell ubiquitination system to mediate intracellular replication in human cells.

The Role of Cytokines during *L. Pneumophila* Infection in Human Cells
======================================================================

Other innate immune mechanisms might modulate *L. pneumophila* infection in human cells, including cytokine production such as Interferon gamma-γ (INF-γ) and Tumor necrosis-α (TNF-α) (Coers et al., [@B22]). Induction of innate immunity includes macrophage activation by the antimicrobial cytokine IFN-γ, protection by TNF-α, and production of IL-6 and IL-1, as well as chemokines from inflammatory cells (Friedman et al., [@B31]). *In vitro* studies with primary human macrophages or cell lines derived from human macrophages that are activated with INF-γ and TNF-α restricted *L. pneumophila* replication (Bhardwaj et al., [@B14]; Nash et al., [@B71]; Matsiota-Bernard et al., [@B68]). Furthermore, pretreatment of hMDM with INF-γ inhibited intracellular replication of *L. pneumophila* and restricted the multiplication of the pathogen (Santic et al., [@B86]). The authors speculate that these processes are distinct between human and mouse macrophages and ultimately determine the permissiveness to *L. pneumophila*. TNF-α has been detected in the broncho-alveolar lavage fluid during *L. pneumophila* infection (Blanchard et al., [@B15]). It is produced readily by human peripheral blood lymphocytes in response to *L. pneumophila* antigens (Friedman et al., [@B31]). TNF-α is a potent cytokine that enhances the bactericidal activity of the macrophages. Furthermore, inhibition of TNF-α production is associated with increased bacterial replication (Nash et al., [@B70]; Matsiota-Bernard et al., [@B68]).

In contrast to the macrophage activating cytokines INF-γ and TNF-α, Interleukin-10 (IL-10) is an inhibitory cytokine. IL-10 treatment significantly enhances *L. pneumophila* growth in monocytes, and completely reverses the protective effect of INF-γ on *L. pneumophila* replication (Park and Skerrett, [@B75]). IL-10 has similar, but less potent, effects on alveolar macrophages and INF-γ-activated alveolar macrophages are less sensitive to deactivation by IL-10. Park and Skerrett ([@B75]) identified important differences in alveolar macrophages and monocytes response to *L. pneumophila* infection and to IL-10. They also suggested that the induction of IL-10 during *L. pneumophila* infection may be a virulence mechanism that promotes intracellular bacterial replication. Therefore, the local balance between the INF-γ and IL-10 production by *L. pneumophila* might determine if monocytes that are recruited to the site of infection will become effector cells or develop into susceptible targets available for bacterial growth.

Cell-mediated immunity seems to play a critical role in restricting *L. pneumophila* replication, and the activated human monocytes have the capacity to inhibit the multiplication of virulent *L. pneumophila* both via decreasing the phagocytosis and the rate of intracellular multiplication (Horwitz and Silverstein, [@B49]). Consistent with that, patients with LD produce less INF-γ than non-LD patients, suggesting that impairment in the INF-γ response may increase the susceptibility to the disease (Lettinga et al., [@B56]). However, patients with acute LD are able to restrict *L. pneumophila* replication as a result elevated level of the Th1-cytokines such as INF-γ and IL-12 (Takeda et al., [@B92]). Sera from patients with *L. pneumophila* contain antibodies to *L. pneumophila* protein antigens (Friedman et al., [@B31]). However, humoral immunity seems to play a limited role in host defense against LD. Horwitz and Silverstein ([@B48]) demonstrated that complement and antibody, which promote entry of *L. pneumophila* into monocytes, do not inhibit the rate of *L. pneumophila* multiplication in monocytes.

Other Immune Responses to *L. Pneumophila* in Human Cells
=========================================================

Another major strategy of innate resistance to intracellular infection is to sequester key nutrients, such as iron, from invading bacteria. Within host cells, iron is predominantly bound to proteins and unavailable in free soluble form. Under iron-limited conditions, *L. pneumophila* secretes a high affinity iron chelator named siderophore, which sequesters iron from the host and the surrounding environment (Liles et al., [@B59]; Cianciotto, [@B20]). *L. pneumophila* utilizes iron to maintain its replication in human monocytes and macrophages. Consistently, treatment of human monocytes and macrophages with iron chelator aborts *L. pneumophila* replication (Gebran et al., [@B34]; Viswanathan et al., [@B96]). Accordingly, restrictive monocytes seem to exhibit low level of expression of transferrin receptor similar to the low level of expression of transferrin receptor in INF-γ activated monocytes (Byrd and Horwitz, [@B17]). Consequently, supplementation of iron abolishes the effect of INF-γ-mediated growth restriction of *L. pneumophila* in hMDM (Santic et al., [@B86]).

Bacterial infection stimulates the production of reactive nitrogen intermediate by the inducible nitric oxide synthase (iNOS). Transcription of NOS2 is mediated by type I and type II interferons; suggesting that the production of nitric oxide (NO) is not an immediate response for the infection. NO mediates its action on bacteria in the vacuole or the cytosol. However, stimulation with 1,25-dihydroxyvitamin D(3) to enhance NO production or the inhibition of NO production by treatment with *N*(G)-methyl-l-arginine did not modify the intracellular multiplication of *L. pneumophila* within MM6. This study suggested that NO radicals do not play a role in restricting different *L. pneumophila* species in human monocytic cell lines (Neumeister et al., [@B73]). So far, the role of NO radicals in human macrophages seems to be controversial (Neumeister et al., [@B73]; Radtke and O\'Riordan, [@B80]).

Genetic Susceptibility to Legionnaires' Disease
===============================================

While the genetic factors that predispose individuals for LD are not well known, it has been shown that TLR5 influences human susceptibility to *L. pneumophila* infection. TLR5 recognizes bacterial flagellin (Hayashi et al., [@B41]) and is the predominant mediator of Interleukin-8 (IL-8) in lung epithelial cells A549. A common stop codon polymorphism in the ligand-binding domain of TLR5 (TLR5^329STOP^) occurs in 10% of the population resulting in the inability to mediate flagellin signaling and is associated with increased risk to LD (Hawn et al., [@B39]). TLR5^329STOP^ has a dominant negative effect and peripheral blood monocytes (PBMCs) from heterozygous individuals stimulated with flagellin had less IL-6 and IL-8 secretion. Likely, TLR5^329STOP^ mutation increases susceptibility to LD by decreasing the cytokine secretion. However, the role of the mouse TLR5 in *L. pneumophila* infection is controversial (Hawn et al., [@B38]; Archer et al., [@B9]). On the other hand, polymorphism in the TLR4 receptor, SNP A896G, is associated with resistance to LD in heterozygous individuals (Hawn et al., [@B40]).

Another factor associated with resistance to *L. pneumophila* infection is the mannose-binding lectin (MBL), a PRR of the innate immune system that activates complement via the lectin pathway (Turner, [@B93]). MBL deficiency compromises opsonization by complement leading to an increased risk of infection. In infection with intracellular pathogens, the role of MBL deficiency is more ambiguous, as more intracellular pathogens use opsonization by MBL to enter their host cell. Herpers et al. ([@B42]) showed that Legionellosis is not associated with MBL deficiency. However, a large number of patients with Legionellosis displayed deficient MBL-mediated complement activation even though they carried MBL-sufficient genotypes. Furthermore, patients with MBL-sufficient genotypes showed functional deficiency at the acute phase of disease, yet the lectin pathway functionality was restored at convalescence. However, the deficiency of lectin pathway seems to be an effect rather than a risk factor for LD development (Herpers et al., [@B42]).

Conclusions
===========

*Legionella pneumophila* exploits several strategies to overcome the innate immune defense in human phagocytes (Figure [1](#F1){ref-type="fig"}). However, most of these converge toward preventing the fusion of its phagosome with the lysosome, inhibiting host cell apoptosis, maintaining host cell survival, modulating the local balance between activating and inhibiting cytokines, sequestering nutrients from the host and overcoming the killing mechanisms available within phagocytes.
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